[Federal Register: April 18, 2007 (Volume 72, Number 74)]
[Notices]               
[Page 19534-19539]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18ap07-71]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA 225-07-4301]

 
Memorandum of Understanding Between the National Cancer Institute 
and the Food and Drug Administration

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between FDA and the National Cancer 
Institute (NCI), part of the National Institutes of Health (NIH) of the 
Department of Health and Human Services (DHHS). The purpose of this MOU 
is to establish a formal collaboration between FDA and NCI regarding 
the creation of a common standards-based data repository to facilitate 
the electronic exchange and analysis of data from research studies on 
investigational drugs in a fully secure manner.

DATES: The agreement became effective March 2, 2007.

FOR FURTHER INFORMATION CONTACT: Randy Levin, Center for Drug 
Evaluation Research (HF-18), Food and Drug Administration, 5600 Fishers 
Lane, Rockville, MD 20857, 301-827-7784 e-mail: 
randy.levin@fda.hhs.gov.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: April 5, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 19535]]

[GRAPHIC] [TIFF OMITTED] TN18AP07.000


[[Page 19536]]


[GRAPHIC] [TIFF OMITTED] TN18AP07.001


[[Page 19537]]


[GRAPHIC] [TIFF OMITTED] TN18AP07.002


[[Page 19538]]


[GRAPHIC] [TIFF OMITTED] TN18AP07.003


[[Page 19539]]


[GRAPHIC] [TIFF OMITTED] TN18AP07.004

[FR Doc. 07-1921 Filed 4-17-07; 8:45 am]

BILLING CODE 4160-01-C